Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate
2008-02-05
2009-08-18
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
C514S002600, C514S008100, C514S012200
Reexamination Certificate
active
07575741
ABSTRACT:
Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule.
REFERENCES:
patent: 6001357 (1999-12-01), Wong et al.
patent: 7332156 (2008-02-01), Bowman et al.
patent: WO 01/18051 (2001-03-01), None
patent: WO 01/85790 (2001-11-01), None
Aggarwal, Sudeepta, and Gurney, Austin L., “IL-17: prototype member of an emerging cytokine family”,J. Leukoc. Biol. 71:1-8; 2002.
Benson, J., et al. (Mar. 22, 2002)FASEB Journal16(5):A1045 abstract, “The role of IL-23 in experimental autoimmune encephalomyelitis”.
Bonifaz, Laura, et al., “Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major HIstocompatibility Complex Class I Products and Peripheral CD8+T Cell Tolerance”,J. Exp. Med., 196(12):1627-1638, Dec. 16, 2002.
Brok, et al., “Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody,”Journal of Immunology(Dec. 1, 2002) 169:6554-6563.
Calhoun, Jason H., et al., “Diabetic Foot Ulcers and Infections: Current Concepts”,Advances in Skin&Wound Care, pp. 31-45, Jan./Feb. 2002.
Cohen, I. Kelman, and Mast, Bruce A., “Models of Wound Healing”,The Journal of Trauma, 30(12 Supp.):S149-155, Dec. 1990.
Cooper, Andrea M., et al., “Mice Lacking Bioactive IL-12 Can Generate Protective, Antigen-Specific Cellular Responses to Mycobacterial Infection Only if the IL-12 p40 Subunit Is Present”,The Journal of Immunology, 168:1322-1327, 2002.
Cordoba-Rodriguez, et al., “IL-23 and IL-27: new members of the growing family of IL-12 related cytokines with important implications for therapeutics,”Expert Opinion on Biological Therapy(Aug. 2003) 3(5):715-723.
Costa, et al., “Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit,”Journal of Immunology(Aug. 15, 2001) 167(4):2379-2387.
Da Costa, Ricardo Marques, et al., “Double-blind Randomized Placebo-controlled Trial of the Use of Granulocyte-Macrophage Colony-stimulating Factor in Chronic Leg Ulcers”,Am. J. Surg., 173:165-168, 1997.
Edde, Lynn, et al., “Lactoferrin protects neonatal rats from gut-related systemic infection”,Am. J. Physiol. Gastrointest Liver Physiol., 281:G1140-G1150, 2001.
Elkins, Karen L., et al., “In Vivo Clearance of an Intracellular Bacterium,Francisella tularensisLVS, Is Dependent on the p40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 p70”,Infection and Immunity, 70(4):1936-1948, Apr. 2002.
Engelhardt, Eva, et al., “Chemokines IL-8, GROα, MCP-1, IP-10, and Mig Are Sequentially and Differentially Expressed During Phase-Specific Infiltration of Leukocyte Subsets in Human Wound Healing”,American Journal of Pathology, 153(6):1849-1860, Dec. 1998.
Gallucci, Randle M., et al., “Interleukin-6 Treatment Augments Cutaneous Wound Healing in Immunosuppressed Mice”,Journal of Interferon and Cytokine Research, 21:603-609, 2001.
Gillitzer, Reinard, and Goebeler, Matthias, “Chemokines in cutaneous wound healing”,Journal of Leukocyte Biology, 69:513-521, Apr. 2001.
Gottrup, Finn, et al., “Models for use in wound healing research: A survey focusing on in vitro and in vivo adult soft tissue”,Wound Repair and Regeneration, 8(2):83-96, 2000.
Grellner, Wolfgang, “Time-dependent immunohistochemical detection of proinflammatory cytokines (IL-1β, IL-6, TNF-α) in human skin wounds”,Forensic Science International, 130:90-96, 2002.
Hölscher, Christoph, et al., “A Protective and Agonistic Function of IL-12p40 in Mycobacterial Infection”,The Journal of Immunology, 167:6957-6966, 2001.
Khavari, P.A., et al., “Cutaneous gene transfer for skin and systemic diseases”,Journal of Internal Medicine, 252:1-10, 2002.
Kraft, William G., et al., “Cutaneous Infection in Normal and Immunocompromised Mice”,Infection and Immunity, 52(3):707-713, Jun. 1986.
Lehmann, Jörg, et al., “IL-12p40-Dependent Agonistic Effects on the Development of Protective Innate and Adaptive Immunity AgainstSalmonellaEnteritidis”,The Journal of Immunology, 167:5304-5315, 2001.
Liu, Wei, et al., “Gene Therapy of Scarring: A Lesson Learned from Fetal Scarless Wound Healing”,Yonsei Medical Journal, 42(6):634-645, 2001.
Maeyama, et al., “Attenuation of Bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12,”American Journal of Physiology, Lung Cellular and Molecular Physiology(Jun. 2001) 280(6):L1128-L1137.
Mikayama et al. (1993)Proc. Nat'l Acad. Sci.(USA) 90:10056 “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor”.
Moulin, Véronique, et al., “Modulated Response to Cytokines of Human Wound Healing Myofibroblasts Compared to Dermal Fibroblasts”,Experimental Cell Research, 238:283-293, 1998.
Oppmann, Birgit, et al., “Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as District from IL-12”,Immunity, 13:715-725, Nov. 2000.
Padigel, Udaikumar M., et al., “The Development of a Th1-Type Response and Resistance toLeishmania majorInfection in the Absence of CD40-CD40L Costimulation”,The Journal of Immunology, 167:5874-5879, 2001.
Parham, Christi, et al., “A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R”,The Journal of Immunology, 168:5699-5708, 2002.
Parks, William C., et al., “Matrilysin in Epithelial Repair and Defense”,Chest, 120(1):36S-41S, Jul. 2001 Supplement.
Payne, Wyatt G., et al, “Long-term outcome study of growth factor-treated pressure ulcers”,The American Journal of Surgery, 181:81-86, 2001.
Presky, et al. (1995)Res. Immunol. 146:439-445 “IL12 receptors and receptor antagonists”.
Schwentker, Ann, et al, “Nitric oxide and wound repair: role of cytokines?”,Nitric Oxide, 7:1-10, 2002.
Singer, Adam J., and Clark, Richard A.F., “Cutaneous Wound Healing”,The New England Journal of Medicine, 341(10):738-746, Sep. 2, 1999.
Schaffer, Christopher J., and Nanney, Lillian B., “Cell Biology of Wound Healing”,International Review of Cytology, 169:151-181, 1996.
Sugawara, Tadaki, et al., “Regulation and Role of Interleukin 6 In Wounded Human Epithelial Keratinocytes”,Cytokine, 15(6):328-336, Sep. 21, 2001.
Sullivan, Tory P., et al., “The pig as a model for human wound healing”,Wound Repair and Regeneration, 9(2):66-76, Mar.-Apr. 2001.
Supplementary Partial European Search Report dated May 18, 2007 in counterpart European Patent Application No. 03814312.9.
Voet et al. (1990)Biochemistry, at pp. 126-128 and 228-234.
Walter, Michael J., et al., “Interleukin 12 p40 Production by Barrier Epithelial Cells during Airway Inflammation”,Journal of Experimental Medicine, 193(3):339-351, Feb. 5, 2001.
Werner, S. and Grose, R., “Regulation of Wound Healing by Growth Factors and Cytokines”,Physiol. Rev., 83:835-870, 2003.
Wiekowski, Maria T., et al., “Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death”,The Journal of Immunology, 166:7563-7570, 2001.
Wilson, Carole L., et al., “Regulation of Intestinal α-Defensin Activation by the Metalloproteinase Matrilysin in Innate Host Defense”,Science, 286:113-117, Oct. 1, 1999.
Bowman Edward P.
Chan Jason R.
Chen Shi-Juan
Cua Daniel J.
Mertz Prema
Schering Corporation
Schering-Plough Patent Dept.
LandOfFree
Methods of treating cutaneous ulcers and grafts using IL-23 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating cutaneous ulcers and grafts using IL-23, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating cutaneous ulcers and grafts using IL-23 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134419